Lataa...
Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide
BACKGROUND: Patients with acute-onset symptomatic atrial fibrillation (AF) can be treated with flecainide. However, flecainide may induce arrhythmias and/or exaggerate heart failure. Therefore, validated markers to predict the efficacy of flecainide and prevent adverse effects are required. We hypot...
Tallennettuna:
| Julkaisussa: | Neth Heart J |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Bohn Stafleu van Loghum
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4352147/ https://ncbi.nlm.nih.gov/pubmed/25884086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-015-0659-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|